Table 1.

Patient characteristics

Sucessfully biopsied patients, N = 948 (%)Matched treatment population, N = 199 (%)
Age at inclusion
N948199
 Median5757
 Range19–8628–86
Sex
 Male485 (51%)85 (43%)
 Female463 (49%)114 (57%)
ECOG performance status
 0348 (46%)88 (50%)
 1396 (52%)86 (49%)
 213 (2%)3 (2%)
 Missing19122
Tumor type
 Head and neck111 (12%)15 (8%)
 Digestive197 (21%)46 (23%)
 Lung170 (18%)32 (16%)
 Bone11 (1%)0 (0%)
 Melanoma12 (1%)3 (2%)
 Mesothelioma and soft tissue26 (3%)4 (2%)
 Breast135 (14%)38 (19%)
 Gynecological, female83 (9%)24 (12%)
 Urological158 (16%)29 (15%)
 Central nervous system1 (0%)0 (0%)
 Thyroid and other endocrine glands8 (1%)2 (1%)
 Ill-defined primary tumor36 (4%)6 (3%)
Metastasis at inclusion
 No (locally advanced)60 (6%)7 (4%)
 Yes887 (94%)192 (96%)
 Missing10
Number of metastatic sites
 Median22
 Range0–90–9
 Missing10
Number of previous therapies for advanced disease
 Median44
 Range0–151–14
 Missing190
RMH prognostic score
 N907194
 Median11
 Range0–30–3
 Missing415